Holen Sie sich die Stockscreener-App
8.315
3.95%
0.385
Schlusskurs vom Vortag:
$7.93
Offen:
$7.92
24-Stunden-Volumen:
769.90K
Relative Volume:
0.29
Marktkapitalisierung:
$922.35M
Einnahmen:
$24.30M
Nettoeinkommen (Verlust:
$-145.57M
KGV:
-6.2519
EPS:
-1.33
Netto-Cashflow:
$-149.17M
1W Leistung:
+2.91%
1M Leistung:
+15.45%
6M Leistung:
+623.11%
1J Leistung:
+143.89%
1-Tages-Spanne:
$7.75
$8.29
1-Wochen-Bereich:
$7.37
$8.27
52-Wochen-Spanne:
$1.03
$9.70
Tango Therapeutics Inc Stock (TNGX) Company Profile
Firmenname
Tango Therapeutics Inc
Sektor
Branche
Telefon
(857) 320-4900
Adresse
201 BROOKLINE AVENUE, BOSTON
Vergleichen Sie TNGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
8.29 | 1.07B | 24.30M | -145.57M | -149.17M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.63 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
666.76 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.06 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
885.87 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.16 | 40.93B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-17 | Eingeleitet | Jefferies | Buy |
| 2024-04-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-08 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-20 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten
How Tango Therapeutics Inc. stock performs in rising dollar environmentJuly 2025 Movers & Precise Swing Trade Entry Alerts - newser.com
Can Tango Therapeutics Inc. stock outperform in 2025 bull marketWeekly Volume Report & Real-Time Market Sentiment Reports - newser.com
Why Tango Therapeutics Inc. is moving todayPortfolio Value Report & Real-Time Market Trend Scan - newser.com
Short interest data insights for Tango Therapeutics Inc.Quarterly Portfolio Report & Breakout Confirmation Trade Signals - newser.com
Long term hold vs stop loss in Tango Therapeutics Inc.Earnings Summary Report & Real-Time Buy Signal Alerts - newser.com
Does Tango Therapeutics Inc. fit your quant trading modelMarket Growth Summary & AI Driven Stock Movement Reports - newser.com
Wall Street Analysts Think Tango Therapeutics (TNGX) Could Surge 52.2%: Read This Before Placing a Bet - MSN
How to build a dashboard for Tango Therapeutics Inc. stockJuly 2025 Momentum & Free Fast Entry Momentum Trade Alerts - newser.com
Why Tango Therapeutics Inc. stock is trending among retail tradersMarket Growth Review & Low Risk High Reward Ideas - newser.com
How strong is Tango Therapeutics Inc. stock balance sheet2025 Biggest Moves & Weekly Stock Performance Updates - fcp.pa.gov.br
Will Tango Therapeutics Inc. stock attract ESG investorsLong Setup & Fast Exit/Entry Strategy Plans - newser.com
Will Tango Therapeutics Inc. stock maintain dividend yieldRisk Management & Smart Swing Trading Techniques - newser.com
Ranking Tango Therapeutics Inc. among high performing stocks via tools2025 Bull vs Bear & Stock Market Timing Techniques - newser.com
Tango Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com
Is Tango Therapeutics Inc. stock entering bullish territoryIPO Watch & Safe Capital Growth Trade Ideas - newser.com
Will Tango Therapeutics Inc. stock reach all time highs in 2025July 2025 Chart Watch & Reliable Breakout Forecasts - Fundação Cultural do Pará
Using AI based signals to follow Tango Therapeutics Inc.Quarterly Market Review & Free High Return Stock Watch Alerts - newser.com
Will Tango Therapeutics Inc. stock outperform tech sector in 2025Portfolio Performance Report & AI Powered Market Entry Strategies - Fundação Cultural do Pará
Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates - MSN
Tango Therapeutics (NASDAQ:TNGX) Releases Quarterly Earnings Results, Beats Estimates By $0.20 EPS - MarketBeat
Tango Therapeutics Reports Promising Q3 2025 Results - TipRanks
Tango Therapeutics Flips To Profit And Banks Fresh Funding - Finimize
Tango Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Tango Therapeutics reports Q3 EPS 14c, consensus (7c) - TipRanks
Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.65%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):